Cognos, an IBM company and world leader in business intelligence and performance management solutions, today announced that MDS Pharma Services has selected IBM Cognos Now! to track and analyze sales performance across its lines of business.
BURLINGTON, Mass. (Business Wire EON) May 6, 2008 --
Cognos, an IBM company and world leader in business
intelligence and performance
management solutions, today announced that MDS Pharma Services has
selected IBM Cognos Now! to track and analyze sales performance across
its lines of business.
MDS Pharma Services, a leading provider of innovative drug discovery and
development solutions for pharmaceutical and biotechnology companies
worldwide, sought a business intelligence (BI) offering that could tap
into its existing customer relationship management (CRM) platform,
enabling stronger customer alignment, a better understanding of its
customer and opportunity pipeline, and improved decision making
capability.
MDS Pharma Services chose IBM Cognos Now!, the industry’s
first BI solution with a continuous business monitoring appliance
designed to help decision makers proactively track, monitor, and respond
to continuously updated operational metrics in real-time or near
real-time.
“IBM Cognos Now! delivers a BI solution that
will significantly enhance our ability to support our clients,”
said David Spaight, President, MDS Pharma Services. “The
automated system will allow our Business Development team to respond to
clients more rapidly with deliverables such as quotes and proposals. The
multi-dimensional views of our data will give us better insight into
client trends and enable us to better anticipate their needs.”
Using IBM Cognos Now!, MDS Pharma Services expects to be able to
generate greater detail and more sophisticated, up-to-date analysis of
their CRM data. Additionally, MDS Pharma Services will use IBM Cognos
Now! to quickly access and analyze financial data from its Oracle
E-Business Suite application.
IBM Cognos Now! empowers business users through highly visual,
interactive and self-service dashboards, analysis and reports to deliver
greater insight and faster, better-informed decision making. IBM Cognos
Now! is a BI solution focused on delivering continuous business
monitoring, prepackaged as an appliance. With IBM Cognos Now!, both
enterprise and small-to-midsized companies can easily integrate multiple
data sources to deploy and maintain a low-cost BI solution that monitors
key business operations metrics. All the software is preconfigured and
can be quickly plugged into an organization's existing infrastructure.
“Operational dashboards that monitor critical
business operations are being implemented more frequently by
organizations to track, monitor, and respond to continuously updated
operational metrics in real time,” said Leah
MacMillan, Vice-President, Product Marketing, Cognos. “Delivered
as an appliance, IBM Cognos Now! is fast and easy to deploy, and is the
perfect solution for companies that want to get started quickly with an
operational BI project. Capitalizing on Cognos, MDS Pharma Services will
now be able to respond quickly to changing metrics, gain a holistic view
into sales performance, and ultimately drive better decision making in
the organization.”
Cognos is a recognized leader in delivering performance management
software for the pharmaceutical industry. Currently, 25 of the top 30
pharmaceutical firms rely on IBM Cognos BI and 17 of the top 25 firms
use IBM Cognos Planning. As well, IBM Cognos software is used by the top
5 biotechnology companies. For more information about IBM Cognos
offerings for pharmaceuticals and life sciences, please visit http://www.cognos.com/solutions/industry/
pharmaceuticals-life-sciences/index.html (Due to its length, this
URL may need to be copied/pasted into your Internet browser's address
field. Remove the extra space if one exists.).
About MDS Pharma Services:
MDS Pharma Services, a business unit of MDS Inc. (TSX:MDS; NYSE:MDZ), is
committed to delivering quality service on time, and offers a full
spectrum of resources to meet the drug discovery and development needs
of the pharmaceutical and biotechnology industries. With numerous
facilities strategically located around the world, MDS Pharma Services
applies advanced scientific and technological expertise throughout the
drug discovery and development process – from
lead optimization, pre-IND research, early clinical research
(bioequivalence, phases I-IIa) and bioanalysis through to global
clinical development (phases IIb-IV), central lab and centralized
cardiac services. For more information, visit the MDS Pharma Services
website at www.mdsps.com.
About Cognos, an IBM company:
Cognos, an IBM company, is the world leader in business
intelligence and performance
management solutions. It provides world-class enterprise planning
and BI software and services to help companies plan, understand and
manage financial and operational performance. Cognos was acquired by IBM
in January 2008. For more information, visit http://www.ibm.com/software/data/
and http://www.cognos.com.
Cognos and the Cognos logo are trademarks of Cognos ULC (formerly Cognos
Incorporated) in the United States and/or other countries. IBM and the
IBM logo are trademarks of International Business Machines Corporation
in the United States, or other countries, or both. Other company,
product, or service names may be trademarks or service marks of others.
Note to Editors: Copies of previous Cognos press releases and Corporate
and product information are available on Cognos' Web site at http://www.cognos.com
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1TcXVhLVN1bW0tRW1wdC1DcmFzLVplcm8=
|
